Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat
- 1 October 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 122 (3) , 423-430
- https://doi.org/10.1038/sj.bjp.0701386
Abstract
Intracellular recordings were made in a pontine slice preparation of the rat brain containing the nucleus locus coeruleus (LC). The pressure application of α,β‐methylene ATP (α,β‐meATP) caused reproducible depolarizations which were depressed by suramin (30 μM) and abolished by suramin (100 μM). Pyridoxal‐phosphate‐6‐azophenyl‐2′,4′‐disulphonic acid (PPADS; 10, 30 μM) also concentration‐dependently inhibited the α,β‐meATP‐induced depolarization, although with a much slower time‐course than suramin. Almost complete inhibition developed with 30 μM PPADS. Reactive blue 2 (30 μM) did not alter the effect of α,β‐meATP, while reactive blue 2 (100 μM) slightly depressed it. Pressure‐applied (S)‐α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) also depolarized LC neurones. Kynurenic acid (500 μM) depressed and 6‐cyano‐7‐nitroquinoxaline‐2,3‐dione (CNQX; 50 μM) abolished the response to AMPA. Suramin (100 μM) potentiated the AMPA effect. Pressure‐applied noradrenaline hyperpolarized LC neurones. Suramin (100 μM) did not alter the effect of noradrenaline. Focal electrical stimulation evoked biphasic synaptic potentials consisting of a fast depolarization (p.s.p.) followed by a slow hyperpolarization (i.p.s.p.). A mixture of D(−)‐2‐amino‐5‐phosphonopentanoic acid (AP‐5; 50 μM), CNQX (50 μM) and picrotoxin (100 μM) depressed both the p.s.p. and the i.p.s.p. Under these conditions suramin (100 μM) markedly inhibited the p.s.p., but did not alter the i.p.s.p. In the combined presence of AP‐5 (50 μM), CNQX (50 μM), picrotoxin (100 μM), strychnine (0.1 μM), tropisetron (0.5 μM) and hexamethonium (100 μM), a high concentration of suramin (300 μM) almost abolished the p.s.p. without changing the i.p.s.p. In the presence of kynurenic acid (500 μM) and picrotoxin (100 μM), PPADS (30 μM) depressed the p.s.p. Moreover, the application of suramin (100 μM) to the PPADS (30 μM)‐containing medium failed to cause any further inhibition. Neither PPADS (30 μM) nor suramin (100 μM) altered the i.p.s.p. It was concluded that the cell somata of LC neurones are endowed with excitatory P2‐purinoceptors. ATP may be released either as the sole transmitter from purinergic neurones terminating at the LC or as a co‐transmitter of noradrenaline from recurrent axon collaterals or dendrites of the LC neurones themselves. British Journal of Pharmacology (1997) 122, 423–430; doi:10.1038/sj.bjp.0701386Keywords
This publication has 50 references indexed in Scilit:
- How should P2x purinoceptors be classified pharmacologically?Trends in Pharmacological Sciences, 1995
- G protein-coupled receptors for ATP and other nucleotides: a new receptor familyTrends in Pharmacological Sciences, 1994
- Purinoceptors: Are there families of P2X and P2Y purinoceptors?Pharmacology & Therapeutics, 1994
- Cloning and functional expression of a brain G‐protein‐coupled ATP receptorFEBS Letters, 1993
- Neuronal ATP receptors and their mechanism of actionTrends in Pharmacological Sciences, 1993
- Pharmacology and electrophysiology of ATP-activated ion channelsTrends in Pharmacological Sciences, 1992
- Noradrenaline-ATP co-transmission in the sympathetic nervous systemTrends in Pharmacological Sciences, 1991
- Basic mechanisms and local modulation of nerve impulse-induced secretion of neurotransmitters from individual sympathetic nerve varicositiesPublished by Springer Nature ,1988
- Effects of purinoceptor agonists on electrophysiological properties of rat mesencephalic trigeminal neurones in vitroNeuroscience Letters, 1988
- The changing face of autonomic neurotransmission*Acta Physiologica Scandinavica, 1986